| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |